Tex. Gov't Code § 2177.001

Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.

Section 2177.001 - Definitions

In this chapter:

(1) "Advisory council" means the Texas Pharmaceutical Initiative Advisory Council established under this chapter.

(2) "Board" means the governing board of the initiative.

(3) "Commission" means the Health and Human Services Commission.

(4) "Generic biological product" means a biological product approved pursuant to an application under Section 351(k), Public Health Service Act (42 U.S.C. Section 262 (k)).

(5) "Generic drug" means a prescription drug approved pursuant to an application under Section 505(j), Federal Food, Drug, and Cosmetic Act (21 U.S.C. Section 355 (j)).

(6) "Initiative" means the Texas Pharmaceutical Initiative established under this chapter.

Tex. Gov't. Code § 2177.001

Added by Acts 2023, Texas Acts of the 88th Leg.- Regular Session, ch. 891,Sec. 1, eff. 6/13/2023.